Overall survival from the open label phase 2 trial of palbociclib in patients with advanced well differentiated/dedifferentiated liposarcoma. An update on the results ...

Durvalumab and tremelimumab combination therapy versus durvalumab monotherapy in metastatic lung cancer: A systematic review and meta-analysis.

The average lifespan of humans is increasing, and with it the percentage of people entering the 65 and older age group is growing rapidly and will continue to do so in the next 20 years. Within this ...